(S1 (S (S (NP (NP (JJ Hierarchical) (NN phosphorylation)) (PP (IN of) (NP (DT the) (NN translation) (NN inhibitor) (NN 4E-BP1))))) (. .)))
(S1 (S (S (PP (IN In) (NP (JJS most) (NNS instances))) (, ,) (NP (NN translation)) (VP (VBZ is) (VP (VBN regulated) (PP (IN at) (NP (DT the) (NN initiation) (NN phase))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (NN ribosome)) (VP (VBZ is) (VP (VBN recruited) (PP (TO to) (NP (NP (DT the) (JJ 5') (NN end)) (PP (IN of) (NP (DT an) (NN mRNA)))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ eIF4E-binding) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NN 4E-BPs)) (-RRB- -RRB-))) (VP (VBP interdict) (NP (NN translation) (NN initiation)) (PP (IN by) (S (VP (VP (VBG binding) (PP (TO to) (NP (DT the) (NN translation) (NN factor) (NN eIF4E)))) (, ,) (CC and) (VP (VBG preventing) (NP (NP (NN recruitment)) (PP (IN of) (NP (DT the) (NN translation) (NN machinery))) (PP (TO to) (NP (NN mRNA)))))))))) (. .)))
(S1 (S (S (NP (DT The) (NNS 4E-BPs)) (VP (VBP inhibit) (NP (NN translation)) (PP (IN in) (NP (DT a) (JJ reversible) (NN manner))))) (. .)))
(S1 (S (S (NP (VBN Hypophosphorylated) (NNS 4E-BPs)) (VP (VBP interact) (ADVP (RB avidly)) (PP (IN with) (NP (NN eIF4E))) (, ,) (SBAR (IN whereas) (S (NP (NP (JJ 4E-BP) (NN hyperphosphorylation)) (, ,) (VP (VBN elicited) (PP (IN by) (NP (NP (NN stimulation)) (PP (IN of) (NP (NNS cells))) (PP (IN with) (NP (NP (NNS hormones)) (, ,) (NP (NNS cytokines)) (, ,) (CC or) (NP (NN growth) (NNS factors))))))) (, ,)) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (NN abrogation)) (PP (IN of) (NP (JJ eIF4E-binding) (NN activity)))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBD reported) (ADVP (RB previously)) (SBAR (SBAR (IN that) (S (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN 4E-BP1))) (PP (IN on) (NP (NP (NN Thr) (CD 37)) (CC and) (NP (NN Thr) (CD 46))))) (VP (VBZ is) (ADJP (RB relatively) (JJ insensitive) (PP (TO to) (NP (NP (NN serum) (NN deprivation)) (CC and) (NP (NN rapamycin) (NN treatment)))))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (NN phosphorylation)) (PP (IN of) (NP (DT these) (NNS residues)))) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NP (DT the) (JJ subsequent) (NN phosphorylation)) (PP (IN of) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (JJ unidentified) (JJ serum-responsive) (NNS sites)))))))))))))) (. .)))
(S1 (S (S (ADVP (RB Here)) (, ,) (S (VP (VBG using) (NP (NN mass) (NN spectrometry)))) (, ,) (NP (PRP we)) (VP (VBP identify) (NP (DT the) (ADJP (ADJP (JJ serum-responsive)) (, ,) (ADJP (JJ rapamycin-sensitive))) (NNS sites)) (PP (IN as) (NP (NP (NN Ser) (CD 65)) (CC and) (NP (NN Thr) (CD 70)))))) (. .)))
(S1 (S (S (S (VP (VBG Utilizing) (NP (NP (DT a) (JJ novel) (NN combination)) (PP (IN of) (NP (NP (JJ two-dimensional) (JJ isoelectric) (NN focusing/SDS-PAGE)) (CC and) (NP (NN Western) (NN blotting)))) (PP (IN with) (NP (JJ phosphospecific) (NNS antibodies)))))) (, ,) (NP (PRP we)) (ADVP (RB also)) (VP (VBP establish) (NP (NP (DT the) (NN order)) (PP (IN of) (NP (NN 4E-BP1) (NN phosphorylation)))) (ADVP (FW in) (FW vivo)))) (: ;) (S (S (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NN Thr) (NN 37/Thr) (CD 46)))) (VP (VBZ is) (VP (VBN followed) (PP (IN by) (NP (NN Thr) (CD 70) (NN phosphorylation)))))) (, ,) (CC and) (S (NP (NN Ser) (CD 65)) (VP (VBZ is) (VP (VBN phosphorylated) (ADVP (RB last)))))) (. .)))
(S1 (S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN phosphorylation)) (PP (IN of) (NP (NP (NN Ser) (CD 65)) (CC and) (NP (NN Thr) (CD 70))))) (ADVP (RB alone)) (VP (VBZ is) (ADJP (JJ insufficient) (S (VP (TO to) (VP (VB block) (NP (NP (NN binding)) (PP (TO to) (NP (NN eIF4E))))))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NN phosphorylation) (NNS events)))) (VP (VBZ is) (ADJP (JJ necessary) (S (VP (TO to) (VP (VBP dissociate) (NP (NN 4E-BP1)) (PP (IN from) (NP (NN eIF4E))))))))))))) (. .)))
